及川伊知郎 (Ichiro Oikawa) - マイポータル

基本情報

所属: 大分大学総合臨床研究センター助教

ORCID iD: https://orcid.org/0000-0001-8628-2843
J-GLOBAL ID: 202401004957970916
researchmap会員ID: R000071721

論文

Fixed Versus Lottery Incentives for Promoting Engagement With a Cadence-Based Smartphone App: Randomized Crossover Trial

Kosuke Hayashi, Hiromitsu Imai, Ichiro Oikawa, Hirokazu Wakuda, Iori Miura, Shingo Uenohara, Asuka Kuwae, Megumi Kai, Ken'ichi Furuya, Naoto Uemura

JMIR Formative Research 2026年5月27日
Utility of Modeling and Simulations in Drug Development: Contrasting Japan, US and UK Descriptions of PBPK Modeling from Package Inserts

Shinji Kudo, Hirokazu Wakuda, Ichiro Oikawa, Ai Sekiguchi, Yusuke Nakamura, Taisuke Hojo, Hiromitsu Imai, Megumi Kai, Naoto Uemura

The AAPS Journal 2026年2月10日
Correction: Assessing Immunogenicity in Drug Reviews and Prescribing Information in Japan.

Mitsuru Ishibai, Megumi Kai, Hirokazu Wakuda, Ichiro Oikawa, Naoto Uemura

The AAPS journal 27(1) 44-44 2025年2月12日
Cadence-Based Pedometer App With Financial Incentives to Enhance Moderate-to-Vigorous Physical Activity: Development and Single-Arm Feasibility Study

Kosuke Hayashi, Hiromitsu Imai, Ichiro Oikawa, Yugo Ishihara, Hirokazu Wakuda, Iori Miura, Shingo Uenohara, Asuka Kuwae, Megumi Kai, Ken'ichi Furuya …

JMIR Formative Research 2024年10月24日査読有り
Assessing Immunogenicity in Drug Reviews and Prescribing Information in Japan.

Mitsuru Ishibai, Megumi Kai, Hirokazu Wakuda, Ichiro Oikawa, Naoto Uemura

The AAPS journal 26(6) 109-109 2024年10月8日査読有り
Flecainide Toxicity From Clinical Pharmacology Perspectives.

Naoyuki Otani, Hirokazu Wakuda, Ichiro Oikawa, Naoto Uemura, Takanori Yasu

Cureus 16(7) e65884 2024年7月査読有り
Effects of rifampicin on the pharmacokinetics and safety of carotegrast methyl in healthy subjects: A randomized 2 × 2 crossover study.

Hiromitsu Imai, Ichiro Oikawa, Tetsuya Koyama, Shunji Matsuki

British journal of clinical pharmacology 90(6) 1395-1407 2024年6月査読有り
Evaluation of the potential drug-drug interactions of carotegrast methyl with midazolam, prednisolone or atorvastatin in healthy adults.

Shunji Matsuki, Ichiro Oikawa, Tetsuya Koyama, Hiromitsu Imai

British journal of clinical pharmacology 90(3) 871-881 2024年3月査読有り
Creating an in vivo hypoxic environment by gas inhalation for the potential evaluation of new pulse oximeters

Naoyuki OTANI, Hirokazu WAKUDA, Masae KURANARI, Ichiro OIKAWA, Hiromitsu IMAI, Naoto UEMURA

Translational and Regulatory Sciences 5(1) 23-27 2023年2月査読有り
Appraisal of ICH E14/S7B Q&As adopted in February 2022 using thorough QT/QTc study data for α4-integrin antagonist carotegrast methyl in Japanese healthy subjects.

Ryuichi Kambayashi, Ai Goto, Hiroko Izumi-Nakaseko, Ichiro Oikawa, Naoki Ikeda, Kazuki Matsuda, Yoshinori Takei, Akio Matsumoto, Yuji Kumagai, Atsushi Sugiyama

Journal of pharmacological sciences 150(3) 191-199 2022年11月査読有り
自然災害時の避難所に必要な薬剤を処方しドローンで供給する際に生じる諸課題

石原優吾, 林宏祐, 倉成正恵, 及川伊知郎, 甲斐(井上) 恵, 山村亮太, 龍田涼佑, 柿本晃治郎, 伊東弘樹, 徳丸治 …

日本臨床薬理学会学術総会抄録集 43 3-C-P-120 2022年
Food Effect on a Single High Dose of Carotegrast Methyl, an Oral Antagonist of α4-Integrin, in Healthy Male Subjects: A Randomised, Placebo-Controlled, Double-Blind Study

Hiroyuki Fukase, Toshifumi Kajioka, Ichiro Oikawa, Naoki Ikeda, Hidetoshi Furuie

Clinical Drug Investigation 40(3) 237-247 2020年3月22日査読有り
AJM300, a novel oral antagonist of α4‐integrin, sustains an increase in circulating lymphocytes: A randomised controlled trial in healthy male subjects

Hiroyuki Fukase, Toshifumi Kajioka, Ichiro Oikawa, Naoki Ikeda, Hidetoshi Furuie

British Journal of Clinical Pharmacology 2020年3月査読有り
Efficacy and safety of once-monthly risedronate in osteoporosis subjects with mild-to-moderate chronic kidney disease: a post hoc subgroup analysis of a phase III trial in Japan.

Toshitsugu Sugimoto, Daisuke Inoue, Masayuki Maehara, Ichiro Oikawa, Takashi Shigematsu, Yoshiki Nishizawa

Journal of bone and mineral metabolism 37(4) 730-740 2019年7月査読有り
Effect of single and multiple doses of elobixibat, an ileal bile acid transporter inhibitor, on chronic constipation: A randomized controlled trial

Yuji Kumagai, Hideki Amano, Yoshinobu Sasaki, Chie Nakagawa, Mika Maeda, Ichiro Oikawa, Hidetoshi Furuie

British Journal of Clinical Pharmacology 2018年10月査読有り
Efficacy and safety of nateglinide plus sitagliptin combination therapy in type 2 diabetes patients inadequately controlled by sitagliptin monotherapy: a phase 3, multicenter, open-label, long-term study.

Takahisa Hirose, Chihiro Saitoh, Ichiro Oikawa, Nobuo Kondo

Diabetology international 9(3) 168-178 2018年7月査読有り

MISC

多量飲酒時の水摂取(チェイサー)が酔いへ与える影響の検討

串尾聡之, 松浦恵子, 門脇真史, 石原優吾, 及川伊知郎, 森一将, 中村彰宏, 外薗英樹, 今井浩光

日本アルコール関連問題学会大会プログラム・抄録集 45th 2023年

及川伊知郎

基本情報

論文

MISC

メニュー

共著者の一覧